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Abstract
Saliva is a useful biofluid for the early detection of disease, but how distal tumors communicate with the oral cavity and
create disease-specific salivary biomarkers remains unclear. Using an in vitro breast cancer model, we demonstrated that
breast cancer-derived exosome-like microvesicles are capable of interacting with salivary gland cells, altering the
composition of their secreted exosome-like microvesicles. We found that the salivary gland cells secreted exosome-like
microvesicles encapsulating both protein and mRNA. We also showed that the interaction with breast cancer-derived
exosome-like microvesicles communicated and activated the transcriptional machinery of the salivary gland cells. Thus, the
interaction altered the composition of the salivary gland cell-derived exosome-like microvesicles on both the
transcriptomically and proteomically.
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Introduction
In an ongoing study, we use saliva, an accessible and non-
invasive biofluid, for the early detection of diseases, such as
Sjo¨gren’s syndrome or pancreatic, breast, and oral cancer [1–4].
Detecting the differential expression of salivary biomarkers
between normal and diseased patients at both the mRNA and
protein level allows us to detect specific diseases efficiently. We
have shown that a combination of four RNA biomarkers (KRAS,
MBD3L2, ACRV1, and DPM1) differentiates pancreatic cancer
patients from non-cancer subjects (chronic pancreatitis and
healthy controls), yielding a receiver operating characteristic
(ROC) plot area under the curve value of 0.971 with 90.0%
sensitivity and 95.0% specificity [4]. Although these translational
and clinical findings provide an innovative breakthrough for the
detection of systemic diseases, how distal systemic diseases mediate
the presence of disease-indicating salivary biomarkers in the oral
cavity remains unclear.
The present study demonstrates that interplay between salivary
gland cells and tumor-derived exosome-like microvesicles induces in
vitro changes in salivary gland cell-derived exosome-like microves-
icles. Exosomes are cell-derived vesicles (30–100 nm in diameter)
that stably reside in many body fluids, including blood, breast milk,
urine, and saliva [5,6,7,8]. Exosomes are formed by the inward
budding of multi-vesicular bodies (MVBs), a component of the
endocytic pathway [9], and consistently manufactured and secreted
into the surrounding extracellular matrix and circulation through
the fusion of MVBs with the plasma membrane [10,11]. Due to
their novelty, the physiological functions of exosomes have not yet
been elucidated. Early studies first proposed that exosomes are
secreted to discard membrane proteins [12]. However, more recent
studies have shown that exosomes also contain antigens that are
capable of triggering a biological immune response by activating T
lymphocytes, natural killer cells, and dendritic cells [13]. Zitvogel et
al. showed that dendritic cell-derived exosomes stimulate T-cell-
mediated anti-tumor immune responses in mice [14]. Dendritic cell-
derived exosomes were also found to express high levels of MHC
class I and class-II peptides that trigger T-cell responses leading to
tumor rejection [15]. Studies have also suggested that exosomes
secreted by metastatic tumors provide interactions between the
tumor front and distal host site, promoting tumor invasion by
transporting RNA between cells, suppressing immune responses,
and promoting angiogenesis [16].
These previous studies demonstrated that exosomes are durable
for travel through body fluids and capable of intercellular
communication. However, whether salivary gland cells are able
to interact and take up tumor-derived exosome-like microvesicles
has not been examined. Moreover, whether the interplay between
tumor-derived exosome-like microvesicles and salivary gland cells
alters salivary gland-derived exosome-like microvesicles is un-
known. Because studies have shown that salivary gland cells
readily secrete exosome-like microvesicles [17], we hypothesized
that tumor-derived exosome-like microvesicles interact with
salivary gland cells and alter the composition of their secreted
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exosome-like microvesicles in an in vitro setting. Using an in vitro
breast cancer model, we investigated whether breast cancer-
derived exosome-like microvesicles can communicate with salivary
gland cells and if this interaction alters the exosome-like
microvesicles released by salivary gland cells.
Methods
Reagents
The following reagents were used: Dulbecco’s Modified Eagle
Medium (DMEM, Invitrogen), fetal bovine serum (FBS, Cellgro),
506 penicillin/streptomycin (P/S, 5000 mg/ml, Cellgro), phos-
phate buffered saline (PBS, Invitrogen), Lipofectamine (Invitro-
gen), paraformaldehyde (Sigma), actinomycin D (ActD, Sigma),
glutaraldehyde (Sigma), uranyl acetate (Sigma), simple stain
solution (Invitrogen), CD63 antibody (Santa Cruz), b-actin
antibody (Sigma), amylase antibody (Abcam), horseradish perox-
idase-coupled secondary antibody (Invitrogen), RNase cocktail
(Ambion), Triton X-100 (Sigma), and methanol (Sigma).
Cell culture
Cells from the human metastatic mammary gland epithelial
adenocarcinoma cell line MDA-MB-231 (231) [18] and human
submandibular gland (HSG) cells [19] were cultured at 37uC with
5% CO2 in DMEM with 10% exosome-free FBS and 16 P/S.
Exosomes were pre-cleared from the FBS via ultracentrifugation at
100,000 g for 2 hours and filtered using a 0.22 mm PVDF filter
(Millipore). Cell count and viability were determined by the Vi-
Cell viability analyzer (Beckman Couture).
Isolation of exosome-like microvesicles
HSG and 231 cells were grown to 80% confluency and incubated
in FBS-free DMEM for 48 hours. The culture supernatant was
centrifuged at 300 g for 10 minutes to remove suspended cells. The
cell pellet was discarded and the supernatant centrifuged at 2000 g
for 10 minutes to remove dead cells, then 10,000 g for 30 minutes
to remove cell debris. Next, the supernatant was centrifuged at
100,000 g for 70 minutes, the supernatant removed, the pellet
washed with PBS and centrifuged at 100,000 g for 70 minutes, then
filtered using a 0.22 mm PVDF syringe filter (Millipore), resulting in
purified exosome-like microvesicles.
Electron microscopy
Isolated exosome-like microvesicles were re-suspended and fixed
with 2% PFA. The microvesicles were then deposited onto
charged carbon-coated grids (Ted Pella) followed by post-fixation
using 1% gluteraldehyde and washed three times with distilled
water. Samples were then contrasted with 2% uranyl–acetate
solution and examined with an electron microscope. Films were
scanned, gamma adjusted, and assembled using Adobe Photoshop
CS, Adobe Illustrator CS, and Image J.
SDS-PAGE and protein staining
Exosome-like microvesicles and cell lysates were re-suspended in
Laemmli Sample Buffer (62.5 mM Tris-HCl pH 6.8, 2% wt/vol
sodium dodecyl sulfate, 50 mM dithiothreitol, 0.01% wt/vol) and
analyzed by sodium dodecyl sulfate polyacrylamide gel electro-
phoresis (SDS-PAGE) followed by staining according to the
manufacturer’s instructions.
Western blotting
The membrane was blocked with 1%milk solution and incubated
with CD63, b-actin, or amylase antibody, followed by incubation
with the appropriate horseradish peroxidase-coupled secondary
antibody. The proteins were detected using the Amersham ECL
Western Blotting Detection System (GE Healthcare).
Exosomal RNA extraction and analysis
HSG and 231-derived exosome-like microvesicles were treated
with RNase cocktail (final concentration 100 U/ml) with or
without 3% Triton X-100 at room temperature for 20 minutes.
Exosomal RNA was extracted from the lysed microvesicles using
the RNeasy Mini Kit (Qiagen) according to the manufacturer’s
instructions. The isolated RNA was analyzed using the RNA 6000
Pico Kit and Bio-analyzer (Agilent).
Communication assays
231-derived exosome-like microvesicles were introduced to
serum-starved HSG cells in DMEM for 12 hours (at 37uC, 5%
CO2), then subsequently washed three times with PBS, trypsin-
ized, detached, and centrifuged to isolate HSG cells for RNA
extraction. Cell count and viability were determined using the Vi-
Cell viability analyzer. As a control, lysed exosome-like microves-
icles (3% Triton X-100 treated) were introduced to HSG cells.
HSG cells were also treated with ActD (0.2 mg/ml) prior to
treatment with 231-derived exosome-like microvesicles for
10 minutes. HSG RNA was extracted using the RNeasy Kit
according to the manufacturer’s instructions. RNA concentrations
were determined using a Nanodrop 3000 (Thermo) and RNA
quality analyzed by the RNA 6000 Nano Kit (Agilent). RNA
concentrations were normalized to cell count. For the microarray
analysis of HSG exosome-like microvesicles, serum-starved HSG
were treated with 231-derived exosome-like microvesicles for
12 hours, washed three times with PBS, and cultured in serum-
free DMEM at 37uC and 5% CO2 for 48 hours. For control
purposes, lysed exosome-like microvesicles were introduced to
HSG cells. Exosome-like microvesicles were isolated from the
HSG culture media by ultracentrifugation. The RNeasy Kit was
utilized to extract RNA from the isolated HSG-derived exosome-
like microvesicles, and the RNA was amplified/purified using the
RiboAMP RNA Amplification Kit (Molecular Devices). The
cDNA was transcribed and biotinylated using the GeneChip
Expression 39-Amplication Kit (Affymetrix). GeneChip (HGU-133
Plus 2.0) hybridization and scanning were performed at the UCLA
Gonda Microarray Core Facility. A heat map of the microarray
results was generated by JMP 9.0.2 (http://www.jmp.com). For
exosomal protein analysis, HSG-derived exosome-like microvesi-
cles (isolated after treatment with 231-derived exosome-like
microvesicles or lysed exosome-like microvesicles) were diluted in
30 ml of PBS and sent to Applied Biomics for 2-dimensional
difference gel electrophoresis (2D-DIGE). An equal amount of
protein sample was labeled with Cy2 as an internal standard.
Experimental and control samples were labeled with Cy3 or Cy5,
and three gels were run for comparative analysis of three separate
preparations. The three gels were matched by the biological
variance analysis module of DeCyder 6.5. Spot volume was
normalized within the gel, and the abundance of each spot was
normalized against the internal Cy2 standard so that spots could
be compared across gels. The ratio of experimental (Exo) to
control (Lys Exo) was calculated for each spot, and the average
ratio and P-values (Student t test and one-way ANOVA) from
three replicate samples were calculated using DeCyder 6.5
software.
U133 Plus 2.0 Array data analysis and gene ranking
Arrays were analyzed using R 2.7.0 (http://www.r-project.org).
The probe logarithmic intensity error estimation (PLIER)
MDA-MB-231 Microvesicles and Salivary Gland Cells
PLoS ONE | www.plosone.org 2 March 2012 | Volume 7 | Issue 3 | e33037
expression measures were computed after background correction
and quantile normalization for each microarray data set. Probe
set-level quantile normalization was performed across all samples
to make the effect sizes similar among all data sets. For every
probe set, the 2-sample t-test was applied to identify differential
expression between samples treated with 231-derived exosome-like
microvesicles or lysed 231-derived exosome-like microvesicles.
After obtaining the estimates and P-values for each probe set, we
corrected the P-values for the false discovery rate. A score was then
generated based on the corrected P-values and differential
expression levels.
Exosome labeling and transfer assay
231-derived exosome-like microvesicles were isolated and
labeled using the PKH26 Red (543 nm excitation) Fluorescent
Cell Linker Mini Kit according to the manufacturer’s directions.
The labeled exosome-like microvesicles were introduced to HSG
cells cultured in DMEM with 10% exosome-free FBS and P/S for
1 hour at 37uC and 5% CO2. For control purposes, lysed labeled
exosome-like microvesicles and PKH only were introduced to
HSG cells. If the PKH molecule is not encapsulated within the
exosome-like microvesicles, the labeling reaction will be stopped
by the serum proteins in the cell medium [20]. Next, HSG cells
were fixed with 100% methanol, washed with PBS, and imaged at
4006 (406 objective and 0.50 numerical aperture) at room
temperature using a Leica DM1L inverted light microscope
attached to a Prior Lumen 200 Argon light-box and Zeiss
Axiocam MRm camera. The images were acquired using
Axiovision Rel. 4.8 software. For quantification, HSG were
trypsinized, centrifuged, re-suspended in PBS, and analyzed via
FACS at the UCLA Flow Cytometry Core. The images were
gamma adjusted and assembled using Adobe Photoshop CS,
Adobe Illustrator CS, and Image J.
Statistical analysis
All graphs were made and statistical analyses performed using R
2.7.0, GraphPad Prism, or Microsoft Excel 2008. All experiments
were performed a minimum of three times. One-way ANOVA
and 2-sample t-tests were used to determine significance (P-
values,0.05). Data are expressed as mean 6 SEM.
Results
HSG and 231-derived exosome-like microvesicles contain
proteins and mRNA
Electron microscopy (58 K and 100 K magnification) images
taken of isolates from the culture media of HSG and 231 cells
showed that they secreted exosome-like microvesicles (Figure
S1A). The isolated exosome-like microvesicles from both cell lines
were between 30–100 nm in size and round with cup-like
concavity. SDS-PAGE analysis found that both HSG and 231
exosome-like microvesicles contained proteins distinct from their
parental cell lysates, and immunoblot detected exosomal marker
CD63 in exosome-like microvesicles from both cell lines (Figure
S1B and C). In addition to the related band at ,40 kDa, both
HSG and 231-derived exosome-like microvesicles expressed CD63
at a distinctly higher molecular weight compared to the CD63
found in their parental cells. To verify that HSG and 231-derived
exosome-like microvesicles contained mRNA, they were treated
with RNase with or without 3% Triton and then analyzed (Figure
S1D and E). For both cell lines, degradation of exosomal mRNA
was observed only after the exosome-like microvesicles were lysed
with 3% Triton, indicating that both HSG and 231-derived
exosome-like microvesicles encapsulated mRNA.
PKH-labeled 231-derived exosome-like microvesicles can
label human salivary gland cells in the presence of serum
proteins
231-derived exosome-like microvesicles were labeled with red
fluorescent lipid linker PKH and then introduced to HSG cells by
adding the labeled exosome-like microvesicles to the conditioned
media with 10% exosome-free FBS. We observed that the PKH
compound from the labeled 231-derived exosome-like microves-
icles transferred to the HSG cells, protecting the PKH26 molecule
from being quenched by the serum (Figure 1). Microscopy showed
that HSG cells were labeled only upon treatment with PKH-
containing 231-derived exosome-like microvesicles, not when
treated with PKH only or PKH-labeled exosome-like microves-
icles lysed with 3% Triton (Figure 1A). FACS analysis confirmed
the significant microscopy results; 49.89610.77% of total HSG
cells were labeled upon treatment with PKH-labeled 231-derived
exosome-like microvesicles. The 2-sample t-test revealed a
significant decrease in the percentage of total HSG cells labeled
upon treatment with PKH only or lysed PKH-labeled exosome-
like microvesicles, as only 3.7760.23% and 15.3260.39% of total
HSG cells were labeled, respectively (Figure 1B).
Up-regulation of total RNA in HSG cells induced by 231-
derived exosome-like microvesicles
Total RNA was up-regulated in HSG cells after treatment with
231-derived exosome-like microvesicles compared to samples
treated with lysed 231-derived exosome-like microvesicles
(Figure 2). Analysis of total cellular RNA from serum-starved
HSG cells detected two ribosomal RNA (rRNA) peaks and a basal
level of cellular RNA. After 12 hours of incubation with 231-
derived exosome-like microvesicles, 2-sample t-test indicated
significantly more total RNA in HSG cells treated with 231-
derived exosome-like microvesicles compared to control
(206.7610.37 ng/ml vs. 349.3696.06 ng/ml, Figure 2B). This
increase in total RNA significantly diminished upon pre-treatment
of the HSG cells with transcription inhibitor ActD (Figure 2B).
HSG cell count and viability were not affected and significantly
different upon treatment with exosome-like microvesicles, lysed
exosome-like microvesicles, or ActD (Figure 2C and D).
HSG-derived exosomal protein content was altered by
231-derived exosome-like microvesicles
231-derived exosome-like microvesicles were introduced to
serum-starved HSG cells for 12 hours and HSG-derived exo-
some-like microvesicles isolated from the media 48 hours later.
The microvesicles were lysed and extracted proteins analyzed via
2D-DIGE (Figure 3). Microvesicles isolated from HSG cells
treated with 231-derived exosome-like microvesicles contained 88
proteins that were present at levels at least1.5-fold higher than in
the control sample. The exosomal proteins that were differentially
packaged ranged in size from larger than 150 KDa to smaller than
15 KDa, and in pH from lower than 4.0 to higher than 8.0.
Interplay between 231-derived exosome-like
microvesicles altered the composition of HSG cell
exosomal mRNA
The comparison of exosomal RNA isolated from HSG cells
treated with 231-derived exosome-like microvesicles or lysed
exosome-like microvesicles (control) revealed 66 significant
mRNAs specific to HSG-derived exosome-like microvesicles
treated with 231-derived exosome-like microvesicles (Table S1).
The heat map of the microarray showed differential mRNA
expression patterns between HSG-derived exosome-like microves-
MDA-MB-231 Microvesicles and Salivary Gland Cells
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icles treated with 231-derived exosome-like microvesicles and the
control (Figure 4A). A gene ontology-based analysis (http://www.
pantherdb.org) implicated the 66 significant mRNAs distinct to
HSG-derived exosome-like microvesicles treated with 231-derived
exosome-like microvesicles in various cellular and physiological
processes, ranging from cell cycle to metabolism (Figure 4B and
C). Furthermore, the composition of HSG-derived exosomal
mRNA was affected by post-treatment with 231-derived exosome-
like microvesicles. Figure 4D and E list the top 10 up- or down-
regulated HSG-derived exosomal mRNA after treatment with
231-derived exosome-like microvesicles with respect to control.
Discussion
Saliva is an effective, non-invasive biofluid for the detection of
various diseases, such as pancreatic, oral, and breast cancer [1]. In
this study, we demonstrated that the interplay between 231-
derived exosome-like microvesicles and HSG cell altered HSG-
Figure 1. PKH-labeled 231-derived exosome-like microvesicles can label human salivary gland cells in the presence of serum. (A)
Microscopy (scale bar = 25 mm) and (B) FACS results showed that HSG cells were labeled after treatment for 1 hour with PKH-labeled 231-derived
exosome-like microvesicles, and minimally labeled when treated only with PKH dye or lysed microvesicles. * P,0.05, ** P,0.01, and *** P,0.001;
n = 3. All experiments were independently performed a minimum of three times.
doi:10.1371/journal.pone.0033037.g001
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Figure 2. Up-regulation of HSG RNA induced by 231-derived exosome-like microvesicles. A) Nano Ladder. (B) Basal RNA level in serum-
starved HSG cells, along with 18 s and 28 s ribosomal RNA peaks. Increased total RNA levels were observed after a 12-hour treatment with 231-
derived exosome-like microvesicles (Exo) compared to lysed 231-derived exosome-like microvesicles (control, Lys Exo). Transcription inhibition by
actinomycin D (ActD) diminished the increase in RNA levels induced by 231-derived exosome-like microvesicles, suggesting that transcription is
activated by 231-derived exosome-like microvesicles. (C) Cell count and (D) cell viability were not affected by the treatments. * P,0.05, ** P,0.01,
and *** P,0.001; n = 6. All experiments were independently performed a minimum of three times.
doi:10.1371/journal.pone.0033037.g002
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derived exosome-like microvesicles. We showed that both HSG
and 231 cells are capable of secreting exosome-like microvesicles
encapsulating protein and mRNA. In addition, we observed that
the PKH-labeled 231-derived exosome-like microvesicles were
able to label HSG cells in the presence of serum. Moreover, the
interplay between 231-derived exosomes and HSG cells activated
the HSG cell transcriptional machinery, inducing an up-regulation
of total cellular RNA. We also discovered that interactions
between HSG cells and 231-derived exosome-like microvesicles
altered the HSG-derived exosome-like microvesicles both proteo-
mically and transcriptomically.
The examination of isolates from the culture media of 231 and
HSG cells showed that both cell lines secreted exosome-like
microvesicles in abundance. Isolates from both 231 and HSG cells
were identified as exosome-like microvesicles due to their size (30–
100 nm) and morphology (round with cuplike concavity). In
addition, the exosomal marker tetraspanin CD63 was found in
both 231- and HSG-derived exosome-like microvesicles. In
addition to the expected band for CD63 at 40 KDa, a 55 KDa
version of CD63 was detected in the exosome-like microvesicle
lysates from both cell lines. The size differences between exosome-
like microvesicle and cell lysate CD63 may be due to the
glycosylation-prone nature of this membrane protein [21].
Moreover, amylase protein was found in HSG-derived exosome-
like microvesicles and the cell lysates (Figure S3), indicating that
HSG cells have acinar cell-like characteristics. We also observed
that HSG readily secreted exosome-like microvesicles encapsulat-
ing both mRNA and proteins, suggesting that these HSG cells are
capable of secreting biomarker-enriched exosome-like microvesi-
cles. These results are consistent with the findings of Gonzales-
Begne et al. [7], who found 914 total parotid gland-derived
exosomal proteins, and with our previous work in which we found
that salivary exosome-like microvesicles contain proteins and
functional mRNA.
The precise mechanism underlying why disease-specific salivary
biomarkers are present in the saliva remains unclear. Studies have
shown that exosomes can stably reside in body fluids, including
urine, blood, milk, and saliva [5–8]. Thus, we believe exosomes
Figure 3. HSG-derived exosomal protein content was altered by 231-derived exosome-like microvesicles. 2D-DIGE identified 88 spots
(circled) differing by 1.5-fold or more were observed compared to HSG-derived exosomal proteins treated with lysed 231-derived exosome-like
microvesicles after treatment with intact 231-derived exosome-like microvesicles (n = 1).
doi:10.1371/journal.pone.0033037.g003
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provide a credible means for intercellular communication. Because
salivary exosomes are released into the saliva via ductal or acinar
cells [22], salivary gland cells may interact with circulating tumor
exosomes in the vasculature and reflect this interaction in the
exosomes secreted into the saliva.
We found that PKH-labeled 231-derived exosome-like micro-
vesicles were capable not only of protecting the PKH molecule
from quenching by serum, but also labeling HSG cells. Thus, even
though we do not show the transference of proteins or mRNA, this
result suggests that 231-derived exosome-like microvesicles are
capable of transferring their exosomal materials to HSG cells.
Because we observed that only approximately half of the HSG cell
populations were labeled, the heterogeneity of the cell line itself
may contribute to this variation in exosome uptake. Thus, to
Figure 4. Interplay between 231-derived exosome-like microvesicles altered the HSG exosomal mRNA composition. (A) Heat map of
microarray analysis results for mRNA transcripts from exosome-like microvesicles isolated from HSG cells treated with 231-derived exosome-like
microvesicles or lysed 231-derived exosome-like microvesicles (control). (B) Ontological analysis of the 66 mRNA transcripts distinct to exosome-like
microvesicles derived from HSG cells that interacted with 231-derived exosome-like microvesicles implicated in various molecular functions and (C)
biological processes. (D, E) Array analysis using R 2.7.0 revealed the top 10 up- or down-regulated HSG-derived exosomal mRNA transcripts after
treatment with 231-derived exosome-like microvesicles with respect to control. The results were generated via three independent trials.
doi:10.1371/journal.pone.0033037.g004
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examine whether the HSG cell population has variations in 231-
derived exosome-like microvesicle uptake, we introduced PKH-
labeled 231-derived exosome-like microvesicles to HSG cells at
various dilutions (1:1, 1:2, 1:4, 1:8). Using fluorescence activated
cell sorting (FACS) we observed a decrease in HSG cell labeling as
the concentration of the input PKH-labeled 231-derived exosome-
like microvesicles decreased (Figure S2). This finding indicates that
the concentration of the labeled 231-derived exosome-like
microvesicles that is introduced and the random encounter and
uptake of these microvesicles by the HSG cells results in the
labeling of ,50% of the cells, rather than the heterogeneity of the
HSG cell population. We also observed that the interactions
between 231-derived exosome-like microvesicles and HSG cells
induced an overall up-regulation of their total RNA levels at the
transcriptional level. However, we were unable to detect any
obvious phenotypic alterations to the HSG cells. Thus, while the
rationale is unclear and beyond the scope of this study, we reason
that there could be multitude of reasons that are at the molecular
and biological levels that may be worthwhile to pursue for future
studies.
The literature suggests several possible mechanisms by which
exosomes can enter a cell, transfer material, and activate
transcription. First, exosomes are capable of fusing with cell
membranes and directly entering the cytoplasm [13]. Alternative-
ly, exosomes can enter a cell passively via clathrin and receptor-
mediated processes [13]. Studies have identified micro-RNA
(miRNA) and transcription factors in exosomes of various origins
[23]. Thus, exosomes may transfer their contents to induce
transcription. Exosomes have also been proposed to interact with a
target cell in a juxtacrine fashion, by ectodomain cleavage leading
to exosomal fragments acting as ligands, or direct fusion with the
target cell [9]. Juxtacrine communication and ectodomain
cleavage are thought to allow exosomal proteins to interact with
the target cell receptors, leading to cell activation.
Here, we showed that the interplay between 231-derived
exosome-like microvesicles and HSG cells in vitro alters the
HSG-derived exosome-like microvesicles proteomically. Several
models have been proposed in regards to exosome uptake and
protein trafficking that may be useful for future investigations into
their mechanism. Due to the heterogeneity of exosomal proteins,
which range from transmembrane proteins to chaperones [9],
exosomal protein packaging may be both endosomal sorting
complex required for transport (ESCRT)-dependent and/or
independent depending on cellular localization [24]. Based on
the proposed models of protein sorting to intra-luminal vesicles
(ILVs) of the MVBs, exosomes internalized into cells via clathrin-
mediated endocytosis are postulated to enter the endosomes for
sorting, and are either sent to the lysosomes for degradation or re-
packaged into the host’s exosomes in an ESCRT-dependent
manner [25]. Alternatively, exosomes may directly fuse with
cellular membranes and unload their cargo proteins into the
target’s cytosol [26]. Thus, the non-specific uptake of cytosolic
proteins during inward budding processes and/or transient
association between cytosolic proteins and transmembrane
proteins may possibly lead to sequestration of the newly acquired
proteins into the re-packaged exosomes.
Translation of exosomal mRNA can also play a role in the
target cell’s exosomal protein composition. Exosomes may
encapsulate transferable and functionally active mRNA, and
exosomal mRNA newly transferred into the target cell’s cytosol
may be translated by free-floating ribosomes [27]. Thus, newly
translated cytosolic proteins may be sequestered into the target
cell’s ILVs of the MVBs during inward budding processes, and
consequently packaged and released in exosomes.
In addition to proteomic changes, microarray analysis revealed
that the interplay between 231-derived exosome-like microvesicles
and HSG cells altered the mRNA composition of HSG-derived
exosome-like microvesicles. The literature suggests that interac-
tions between exosomal ligands and cellular receptors can induce
cellular activation, leading to nascent mRNA transcripts [9].
Therefore, the direct fusion of exosomes with the target cell can
lead to unloading of exosomal mRNA into the cytosol where basal
inward budding processes occur and trigger the sequestration of
novel exosomal mRNA into newly synthesized exosomes.
Here, we showed that the interplay between 231-derived
exosome-like microvesicles alters HSG-derived exosome-like micro-
vesicles both transcriptomically and proteomically. However,
because this is an in vitro study, we are unable to make the
assumption that breast cancer cell-derived exosomes induce breast
cancer-specific biomarkers released from the salivary glands. Instead,
based on our observations, we can suggest that within an in vivo
setting, if breast cancer-derived exosome-like microvesicles were to
reach the salivary glands, and if breast cancer-derived exosome-like
microvesicles are internalized by the salivary gland cells, the
composition of released salivary gland-derived exosome-like micro-
vesicles will change both transcriptomically and proteomically.
The mechanism underlying the alteration of HSG-derived
exosomal composition is unknown. However, previous findings in
regards to exosomal biogenesis and cellular cargo trafficking
provide us a solid foundation for further investigation. Examining
how acquired cancer-derived exosomal contents are packaged in
salivary gland cell-derived exosomes will be crucial for decoding
the mechanism underlying the existence of salivary biomarkers.
Furthermore, understanding how cancer-derived exosomes enter
the salivary gland cells will provide us with a clue as to whether
salivary biomarkers are directly derived from the disease source
(i.e. exosomes enter the salivary gland cells, are packaged into
MVBs, and released) or whether secondary messengers are
involved (i.e. exosomes unload mRNA into salivary gland cells,
mRNA is translated by free cytosolic ribosomes, and newly
synthesized peptides are sequestered and released).
Supporting Information
Figure S1 HSG and 231 cells secreted exosome-like
microvesicles containing proteins and mRNA. (A) HSG
and 231-derived exosome-like microvesicles were isolated from
culture media and visualized by electron microscopy (scale
bar=100 nm). (B) SDS-PAGE of exosomal lysates from HSG and
231 cells revealed distinct protein composition compared to their
parental cell lysates. (C) Both 231- and HSG-derived exosome-like
microvesicles contained the exosomal marker CD63. (D) Agilent Bio-
Analyzer Pico analysis shows that mRNA is encapsulated in exosome-
like microvesicles derived from HSG and (E) 231 cells. When treated
with 3% Triton to lyse the exosome-like microvesicles, RNase was
able to readily degrade the exosomal mRNA. All experiments were
independently performed a minimum of three times.
(TIF)
Figure S2 FACS analysis of PKH labeling of HSG cells
by 231-derived exosome-like microvesicles at various
dilutions. FACS analysis demonstrated that the labeling of HSG
cells by PKH-labeled 231-derived exosome-like microvesicles
decreases as the input concentration of PKH-labeled 231-derived
exosome-like microvesicles decreases.
(TIF)
Figure S3 Amylase protein is found in HSG cells and
HSG-derived exosome-like microvesicles. Western blot
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revealed that amylase protein is produced in HSG cells and also
secreted in HSG-derived exosome-like microvesicles. Amylase protein
found in HSG cell lysates had a molecular weight of ,56 KDa,
whereas the amylase protein found in HSG-derived exosome-like
microvesicles was ,56 KDa and ,62 KDa due to differential
glycosylation. Amylase protein was not found in 231 cell lysates.
(TIF)
Table S1 Interplay between 231-derived exosome-like
microvesicles and HSG cells altered the composition of
exosomal mRNA in HSG cells. We found 66 significant
mRNA transcripts specific to HSG-derived exosome-like micro-
vesicles treated with 231-derived exosome-like microvesicles after
three independent trials.
(PDF)
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